SLRN - ACELYRIN, Inc.
2.27
0.040 1.762%
Share volume: 4,076,542
Last Updated: 05-20-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.23
0.04
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-19-2025 | 05-14-2025 | |
| Cash flow financing | 2.807 M | -289.000 K | 1.006 M | 1.869 M | 5.000 K | |
| Other financing cash flows | 2.807 M | -2.807 M | 0.000 | -1.937 M | 5.000 K | |
| Cash flow | 46.404 M | -135.747 M | 88.116 M | -142.436 M | -15.619 M | |
| Net income | -34.973 M | -85.672 M | -48.548 M | -79.033 M | -55.264 M | |
| Depreciation | 55.000 K | 116.000 K | 106.000 K | 146.000 K | 113.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 100.896 M | -89.183 M | 165.874 M | -22.722 M | 23.331 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 55.000 K | 814.000 K | 297.000 K | 81.000 K | 1.000 K | |
| Cash Change | 46.404 M | -135.747 M | 88.116 M | -142.436 M | -15.619 M |